Who has invested in Bonum Therapeutics?

Roche Venture Fund, Vivo Capital are named among the investors backing Bonum Therapeutics.

Bonum Therapeutics Funding: $93M Raised, Series A (2022)

Bonum Therapeutics funding overview

Bonum Therapeutics is based in Seattle. Bonum Therapeutics has raised $93M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for Bonum Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Roche Venture Fund, Vivo Capital. 2 distinct backers are named across the disclosed rounds.

Bonum Therapeutics at a glance

Total raised: $93M
Latest round: Series A
Latest round date: January 2022
Headquarters: Seattle
Notable investors: Roche Venture Fund, Vivo Capital

Frequently asked about Bonum Therapeutics funding

How much has Bonum Therapeutics raised?: Bonum Therapeutics has raised $93M in total disclosed funding across the rounds on record.
Who has invested in Bonum Therapeutics?: Roche Venture Fund, Vivo Capital are named among the investors backing Bonum Therapeutics.
What was the latest Bonum Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2022.
Where is Bonum Therapeutics based?: Bonum Therapeutics is based in Seattle.
When did Bonum Therapeutics last raise?: The last disclosed Bonum Therapeutics round closed in January 2022 at Series A.

We update the Bonum Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Seattle and their backers are listed below.

Bonum Therapeutics Funding: $93M Raised, Series A (2022)

Bonum Therapeutics funding overview

Bonum Therapeutics at a glance

Frequently asked about Bonum Therapeutics funding

Companies related to Bonum Therapeutics (36)

Browse related funding lists (7)